Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ENSG00000224067 encodes a pseudogene with similarity to a portion of the HLA-B associated transcript 2 (BAT2) region[3]. Pseudogenes in the HLA locus are typically non-coding genomic elements that resemble functional HLA genes but usually do not encode a functional protein product[4]. There is no direct evidence that this specific pseudogene produces a functional protein or acts as a conventional therapeutic target like a receptor or enzyme. However, some pseudogenes, especially in the HLA region, may be transcribed and can play regulatory roles at the RNA level, potentially influencing immune system function or gene expression[2][1]. For ENSG00000224067 specifically, no current data show it acts as a therapeutic target or binds any known drugs, but pseudogenes in this region may have roles in disease susceptibility and cancer biology, generally by modulating gene regulation rather than acting as direct therapeutic targets[2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pseudogene similar to part of HLA-B associated transcript 2.